Gastric microbiota and its role in gastric carcinogenesis

Abstract

Gastric cancer (GC) is one of the most common malignancies globally, the occurrence of which undergoes a multistage chronic evolutionary process. It is a great public health issue to deeply understand the mechanisms of GC development and factors affecting the evolution of gastric lesions. Helicobacter pylori infection has been identified as one of the main factors for gastric carcinogenesis and microbial dysbiosis. With the advances in molecular biology techniques, other gastric microbes besides H. pylori have been observed to play an essential role in the development of GC. Previous animal model studies suggested that specific and critical microbes in the stomach can accelerate the malignant transformation of gastric mucosa and the progression of gastric lesions to GC. Recently, the composition of human gastric microbiota has been investigated from stages of precancerous lesions to GC, including characteristics of gastric microbiota diversity, lesion‐associated differential microbes, predicted microbiota‐related functions, microbiota interactions, and microbial mechanisms in gastric carcinogenesis. In this review, we provide an overview of the gastric microbiota, summarize current studies exploring the roles of microbiota in gastric carcinogenesis, and illustrate the significance and prospects of integrative multiomics analysis combined with the microbiome in gastric carcinogenesis.

Keywords

gastric cancer / premalignant lesions / carcinogenesis / microbiota / specific microbes

References

[1] Schwartz DJ , Langdon AE , Dantas G . Understanding the impact of antibiotic perturbation on the human microbiome. Genome Med. 2020; 12 (1): 82.

[2] Abreu MT , Peek Jr. RM . Gastrointestinal malignancy and the microbiome. Gastroenterology. 2014; 146 (6): 1534- 1546.

[3] Hollister EB , Gao C , Versalovic J . Compositional and functional features of the gastrointestinal microbiome and their effects on human health. Gastroenterology. 2014; 146 (6): 1449- 1458.

[4] Sung H , Ferlay J , Siegel RL , et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71 (3): 209- 249.

[5] Wroblewski LE , Peek Jr. RM , Wilson KT . Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010; 23 (4): 713- 739.

[6] Correa P . Human gastric carcinogenesis: a multistep and multifactorial process—first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992; 52 (24): 6735- 6740.

[7] Helicobacter and Cancer Collaborative Group . Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut. 2001; 49 (3): 347- 353.

[8] de Martel C , Georges D , Bray F , Ferlay J , Clifford GM . Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020; 8 (2): e180- e190.

[9] Liu X , Shao L , Liu X , et al. Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer. EBioMedicine. 2019; 40: 336- 348.

[10] Lertpiriyapong K , Whary MT , Muthupalani S , et al. Gastric colonisation with a restricted commensal microbiota replicates the promotion of neoplastic lesions by diverse intestinal microbiota in the Helicobacter pylori INS-GAS mouse model of gastric carcinogenesis. Gut. 2014; 63 (1): 54- 63.

[11] Lofgren JL , Whary MT , Ge Z , et al. Lack of commensal flora in Helicobacter pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology. 2011; 140 (1): 210- 220.

[12] Bacteria, and the germ‐theory of disease: on the relations of microorganisms to disease. Science. 1884; 3 (52): 133- 135.

[13] Ohno H , Satoh-Takayama N . Stomach microbiota, Helicobacter pylori, and group 2 innate lymphoid cells. Exp Mol Med. 2020; 52 (9): 1377- 1382.

[14] Warren JR , Marshall B . Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983; 1 (8336): 1273- 1275.

[15] Andersson AF , Lindberg M , Jakobsson H , Bäckhed F , Nyrén P , Engstrand L . Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One. 2008; 3 (7): e2836.

[16] Li XX , Wong GLH , To KF , et al. Bacterial microbiota profiling in gastritis without Helicobacter pylori infection or non-steroidal anti-inflammatory drug use. PLoS One. 2009; 4 (11): e7985.

[17] Simon GL , Gorbach SL . Intestinal flora in health and disease. Gastroenterology. 1984; 86 (1): 174- 193.

[18] Korecka A , Arulampalam V . The gut microbiome: scourge, sentinel or spectator? J Oral Microbiol. 2012; 4: 9367.

[19] O'Hara AM , Shanahan F . The gut flora as a forgotten organ. EMBO Rep. 2006; 7 (7): 688- 693.

[20] Martinez-Guryn K , Leone V , Chang EB . Regional diversity of the gastrointestinal microbiome. Cell Host Microbe. 2019; 26 (3): 314- 324.

[21] Hunt RH , Camilleri M , Crowe SE , et al. The stomach in health and disease. Gut. 2015; 64 (10): 1650- 1668.

[22] Martinsen TC , Bergh K , Waldum HL . Gastric juice: a barrier against infectious diseases. Basic Clin Pharmacol Toxicol. 2005; 96 (2): 94- 102.

[23] Bik EM , Eckburg PB , Gill SR , et al. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA. 2006; 103 (3): 732- 737.

[24] Ferreira RM , Pereira-Marques J , Pinto-Ribeiro I , et al. Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018; 67 (2): 226- 236.

[25] He C , Peng C , Shu X , et al. Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis. Gastric Cancer. 2022; 25 (5): 837- 849.

[26] Schulz C , Schütte K , Koch N , et al. The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection. Gut. 2018; 67 (2): 216- 225.

[27] Maldonado-Contreras A , Goldfarb KC , Godoy-Vitorino F , et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011; 5 (4): 574- 579.

[28] Plummer M , Franceschi S , Vignat J , Forman D , de Martel C . Global burden of gastric cancer attributable to Helicobacter pylori. Int J Cancer. 2015; 136 (2): 487- 490.

[29] Li WQ , Zhang JY , Ma JL , et al. Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial. BMJ. 2019; 366: l5016.

[30] Liou JM , Malfertheiner P , Lee YC , et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus. Gut. 2020; 69 (12): 2093- 2112.

[31] Rugge M , Genta RM , Di Mario F , et al. Gastric cancer as preventable disease. Clin Gastroenterol Hepatol. 2017; 15 (12): 1833- 1843.

[32] Liou JM , Lee YC , El‐Omar EM , Wu MS . Efficacy and long‐term safety of H. pylori eradication for gastric cancer prevention. Cancers (Basel). 2019; 11 (5): 593.

[33] Mason KL , Erb Downward JR , Falkowski NR , Young VB , Kao JY , Huffnagle GB . Interplay between the gastric bacterial microbiota and Candida albicans during postantibiotic recolonization and gastritis. Infect Immun. 2012; 80 (1): 150- 158.

[34] Guo Y , Zhang Y , Gerhard M , et al. Effect of Helicobacter pylori on gastrointestinal microbiota: a population-based study in Linqu, a high-risk area of gastric cancer. Gut. 2020; 69 (9): 1598- 1607.

[35] Mao LQ , Zhou YL , Wang SS , et al. Impact of Helicobacter pylori eradication on the gastric microbiome. Gut Pathog. 2021; 13 (1): 60.

[36] Sung JJY , Coker OO , Chu E , et al. Gastric microbes associated with gastric inflammation, atrophy and intestinal metaplasia 1 year after Helicobacter pylori eradication. Gut. 2020; 69 (9): 1572- 1580.

[37] Oshima T , Miwa H . Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases. J Neurogastroenterol Motil. 2018; 24 (3): 334- 344.

[38] Pounder RE . Histamine H2-receptor antagonists and gastric acid secretion. Pharmacol Ther. 1984; 26 (2): 221- 234.

[39] Bruno G , Zaccari P , Rocco G , et al. Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified. World J Gastroenterol. 2019; 25 (22): 2706- 2719.

[40] Freedberg DE , Lebwohl B , Abrams JA . The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med. 2014; 34 (4): 771- 785.

[41] Yuan Z , Xiao S , Li S , et al. The impact of Helicobacter pylori infection, eradication therapy, and probiotics intervention on gastric microbiota in young adults. Helicobacter. 2021; 26 (6): e12848.

[42] Ojetti V , Bruno G , Ainora ME , et al. Impact of Lactobacillus reuteri supplementation on anti-Helicobacter pylori levofloxacin-based second-line therapy. Gastroenterol Res Pract. 2012; 2012: 740381.

[43] Du YQ , Su T , Fan JG , et al. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World J Gastroenterol. 2012; 18 (43): 6302- 6307.

[44] Bashir M , Prietl B , Tauschmann M , et al. Effects of high doses of vitamin D3 on mucosa-associated gut microbiome vary between regions of the human gastrointestinal tract. Eur J Nutr. 2016; 55 (4): 1479- 1489.

[45] Arita S , Inagaki‐Ohara K . High‐fat‐diet‐induced modulations of leptin signaling and gastric microbiota drive precancerous lesions in the stomach. Nutrition. 2019; 67- 68:110556.

[46] Sahasakul Y , Takemura N , Sonoyama K . Different impacts of purified and nonpurified diets on microbiota and Toll-like receptors in the mouse stomach. Biosci Biotechnol Biochem. 2012; 76 (9): 1728- 1732.

[47] Chen XH , Wang A , Chu AN , Gong YH , Yuan Y . Mucosa-associated microbiota in gastric cancer tissues compared with non-cancer tissues. Front Microbiol. 2019; 10: 1261.

[48] Crusell MKW , Hansen TH , Nielsen T , et al. Gestational diabetes is associated with change in the gut microbiota composition in third trimester of pregnancy and postpartum. Microbiome. 2018; 6 (1): 89.

[49] Tang WHW , Wang Z , Levison BS , et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368 (17): 1575- 1584.

[50] Vasapolli R , Schütte K , Schulz C , et al. Analysis of transcriptionally active bacteria throughout the gastrointestinal tract of healthy individuals. Gastroenterology. 2019; 157 (4): 1081- 1092.

[51] Gopalakrishnan V , Helmink BA , Spencer CN , Reuben A , Wargo JA . The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell. 2018; 33 (4): 570- 580.

[52] Dicksved J , Lindberg M , Rosenquist M , Enroth H , Jansson JK , Engstrand L . Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol. 2009; 58 (pt 4): 509- 516.

[53] Yu G , Torres J , Hu N , et al. Molecular characterization of the human stomach microbiota in gastric cancer patients. Front Cell Infect Microbiol. 2017; 7: 302.

[54] Coker OO , Dai Z , Nie Y , et al. Mucosal microbiome dysbiosis in gastric carcinogenesis. Gut. 2018; 67 (6): 1024- 1032.

[55] Liu D , Chen S , Gou Y , et al. Gastrointestinal microbiota changes in patients with gastric precancerous lesions. Front Cell Infect Microbiol. 2021; 11: 749207.

[56] Zhou CB , Pan SY , Jin P , et al. Fecal signatures of Streptococcus anginosus and Streptococcus constellatus for noninvasive screening and early warning of gastric cancer. Gastroenterology. 2022; 162 (7): 1933- 1947.

[57] Png CW , Lee WJJ , Chua SJ , Zhu F , Yeoh KG , Zhang Y . Mucosal microbiome associates with progression to gastric cancer. Theranostics. 2022; 12 (1): 48- 58.

[58] Wu F , Yang L , Hao Y , et al. Oral and gastric microbiome in relation to gastric intestinal metaplasia. Int J Cancer. 2022; 150 (6): 928- 940.

[59] Yang Y , Dai D , Jin W , et al. Microbiota and metabolites alterations in proximal and distal gastric cancer patients. J Transl Med. 2022; 20 (1): 439.

[60] Wang Z , Gao X , Zeng R , et al. Changes of the gastric mucosal microbiome associated with histological stages of gastric carcinogenesis. Front Microbiol. 2020; 11: 997.

[61] Castaño-Rodríguez N , Goh KL , Fock KM , Mitchell HM , Kaakoush NO . Dysbiosis of the microbiome in gastric carcinogenesis. Sci Rep. 2017; 7 (1): 15957.

[62] Gantuya B , El Serag HB , Matsumoto T , et al. Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions. Aliment Pharmacol Ther. 2020; 51 (8): 770- 780.

[63] Shi L , Fan Q , Zhou B , et al. The composition and functional profile of the microbial communities in human gastric cancer tissues and adjacent normal tissues. Acta Biochim Biophys Sin (Shanghai). 2022; 54 (1): 47- 54.

[64] Aviles-Jimenez F , Vazquez-Jimenez F , Medrano-Guzman R , Mantilla A , Torres J . Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep. 2014; 4: 4202.

[65] Sun QH , Zhang J , Shi YY , Zhang J , Fu WW , Ding SG . Microbiome changes in the gastric mucosa and gastric juice in different histological stages of Helicobacter pylori-negative gastric cancers. World J Gastroenterol. 2022; 28 (3): 365- 380.

[66] Kadeerhan G , Gerhard M , Gao JJ , et al. Microbiota alteration at different stages in gastric lesion progression: a population-based study in Linqu, China. Am J Cancer Res. 2021; 11 (2): 561- 575.

[67] Pimentel-Nunes P , Barros A , Pita I , et al. Gastric microbiome profile throughout gastric carcinogenesis: beyond helicobacter. Scand J Gastroenterol. 2021; 56 (6): 708- 716.

[68] Wang L , Zhou J , Xin Y , et al. Bacterial overgrowth and diversification of microbiota in gastric cancer. Eur J Gastroenterol Hepatol. 2016; 28 (3): 261- 266.

[69] Hu YL , Pang W , Huang Y , Zhang Y , Zhang CJ . The gastric microbiome is perturbed in advanced gastric adenocarcinoma identified through shotgun metagenomics. Front Cell Infect Microbiol. 2018; 8: 433.

[70] Wu ZF , Zou K , Wu GN , et al. A comparison of tumor-associated and non-tumor-associated gastric microbiota in gastric cancer patients. Dig Dis Sci. 2021; 66 (5): 1673- 1682.

[71] Deng Y , Ding X , Song Q , et al. Alterations in mucosa-associated microbiota in the stomach of patients with gastric cancer. Cell Oncol. 2021; 44 (3): 701- 714.

[72] Ndegwa N , Ploner A , Andersson AF , et al. Gastric microbiota in a low-Helicobacter pylori prevalence general population and their associations with gastric lesions. Clin Transl Gastroenterol. 2020; 11 (7): e00191.

[73] Shao D , Vogtmann E , Liu A , et al. Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. Cancer. 2019; 125 (22): 3993- 4002.

[74] Zhang Y , Shen J , Shi X , et al. Gut microbiome analysis as a predictive marker for the gastric cancer patients. Appl Microbiol Biotechnol. 2021; 105 (2): 803- 814.

[75] Li F , Zhu H , Tao K , et al. Mucosal microbial microenvironment in early gastric neoplasia and non-neoplastic gastric disease. J Gastroenterol Hepatol. 2021; 36 (11): 3092- 3101.

[76] Hsieh YY , Tung SY , Pan HY , et al. Increased abundance of clostridium and fusobacterium in gastric microbiota of patients with gastric cancer in Taiwan. Sci Rep. 2018; 8 (1): 158.

[77] Gunathilake MN , Lee J , Choi IJ , et al. Association between the relative abundance of gastric microbiota and the risk of gastric cancer: a case-control study. Sci Rep. 2019; 9 (1): 13589.

[78] Gevers D , Kugathasan S , Denson LA , et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe. 2014; 15 (3): 382- 392.

[79] Yang I , Woltemate S , Piazuelo MB , et al. Different gastric microbiota compositions in two human populations with high and low gastric cancer risk in Colombia. Sci Rep. 2016; 6: 18594.

[80] Chen X , Xia C , Li Q , Jin L , Zheng L , Wu Z . Comparisons between bacterial communities in mucosa in patients with gastric antrum ulcer and a duodenal ulcer. Front Cell Infect Microbiol. 2018; 8: 126.

[81] Llorca L , Pérez-Pérez G , Urruzuno P , et al. Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status. Pediatr Infect Dis J. 2017; 36 (2): 173- 178.

[82] Paroni Sterbini F , Palladini A , Masucci L , et al. Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients. Appl Environ Microbiol. 2016; 82 (22): 6633- 6644.

[83] Ren R , Wang Z , Sun H , et al. The gastric mucosal-associated microbiome in patients with gastric polyposis. Sci Rep. 2018; 8 (1): 13817.

[84] Gunathilake M , Lee J , Choi IJ , Kim YI , Kim J . Association between bacteria other than Helicobacter pylori and the risk of gastric cancer. Helicobacter. 2021; 26 (5): e12836.

[85] Higashi H , Tsutsumi R , Muto S , et al. SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein. Science. 2002; 295 (5555): 683- 686.

[86] Higashi H , Tsutsumi R , Fujita A , et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci USA. 2002; 99 (22): 14428- 14433.

[87] Lopes AI , Quiding-Jarbrink M , Palha A , et al. Cytokine expression in pediatric Helicobacter pylori infection. Clin Diagn Lab Immunol. 2005; 12 (8): 994- 1002.

[88] Beswick EJ. H . pylori and host interactions that influence pathogenesis. World J Gastroenterol. 2006; 12 (35): 5599- 5605.

[89] Blaser N , Backert S , Pachathundikandi SK . Immune cell signaling by Helicobacter pylori: impact on gastric pathology. Adv Exp Med Biol. 2019; 1149: 77- 106.

[90] Tjalsma H , Boleij A , Marchesi JR , Dutilh BE . A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012; 10 (8): 575- 582.

[91] Peterson W , Lee E , Skoglund M . The role of Campylobacter pyloridis in epidemic gastritis with hypochlorhydria. Gastroenterology. 1987; 92 (5): 1575.

[92] El-Omar EM , Rabkin CS , Gammon MD , et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003; 124 (5): 1193- 1201.

[93] Sanduleanu S , Jonkers D , De Bruine A , Hameeteman W , Stockbrügger RW . Non-Helicobacter pylori bacterial flora during acid-suppressive therapy: differential findings in gastric juice and gastric mucosa. Aliment Pharmacol Ther. 2001; 15 (3): 379- 388.

[94] Ling Z , Shao L , Liu X , et al. Regulatory T cells and plasmacytoid dendritic cells within the tumor microenvironment in gastric cancer are correlated with gastric microbiota dysbiosis: a preliminary study. Front Immunol. 2019; 10: 533.

[95] Han H , Lee SY , Oh S , Moon H , Cho H , Kim JH . Correlations of the gastric and duodenal microbiota with histological, endoscopic, and symptomatic gastritis. J Clin Med. 2019; 8 (3): 312.

[96] Lam SY , Yu J , Wong SH , Peppelenbosch MP , Fuhler GM . The gastrointestinal microbiota and its role in oncogenesis. Best Pract Res Clin Gastroenterol. 2017; 31 (6): 607- 618.

[97] Pachathundikandi SK , Lind J , Tegtmeyer N , El-Omar EM , Backert S . Interplay of the gastric pathogen Helicobacter pylori with Toll-like receptors. BioMed Res Int. 2015; 2015: 192420.

[98] Brandi G , Biavati B , Calabrese C , et al. Urease-positive bacteria other than Helicobacter pylori in human gastric juice and mucosa. Am J Gastroenterol. 2006; 101 (8): 1756- 1761.

[99] Gobert AP , Mersey BD , Cheng Y , Blumberg DR , Newton JC , Wilson KT . Cutting edge: urease release by Helicobacter pylori stimulates macrophage inducible nitric oxide synthase. J Immunol. 2002; 168 (12): 6002- 6006.

[100] Suerbaum S , Michetti P . Helicobacter pylori infection. N Engl J Med. 2002; 347 (15): 1175- 1186.

[101] Mowat C , Williams C , Gillen D , et al. Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000; 119 (2): 339- 347.

[102] Dong T , Feng Q , Liu F , et al. Alteration of stomach microbiota compositions in the progression of gastritis induces nitric oxide in gastric cell. Exp Ther Med. 2017; 13 (6): 2793- 2800.

[103] Alarcón T , Llorca L , Perez-Perez G . Impact of the microbiota and gastric disease development by Helicobacter pylori. Curr Top Microbiol Immunol. 2017; 400: 253- 275.

[104] Winter SE , Winter MG , Xavier MN , et al. Host‐derived nitrate boosts growth of E. coli in the inflamed gut. Science. 2013; 339 (6120): 708- 711.

[105] Fei Y , Liu D , Luo T , et al. Molecular characterization of Lactobacillus plantarum DMDL 9010, a strain with efficient nitrite degradation capacity. PLoS One. 2014; 9 (11): e113792.

[106] Ushiki N , Fujitani H , Aoi Y , Tsuneda S . Isolation of Nitrospira belonging to sublineage II from a wastewater treatment plant. Microbes Environ. 2013; 28 (3): 346- 353.

[107] Rossi T , Vergara D , Fanini F , Maffia M , Bravaccini S , Pirini F . Microbiota-derived metabolites in tumor progression and metastasis. Int J Mol Sci. 2020; 21 (16): 5786.

[108] Tang Q , Cang S , Jiao J , et al. Integrated study of metabolomics and gut metabolic activity from ulcerative colitis to colorectal cancer: the combined action of disordered gut microbiota and linoleic acid metabolic pathway might fuel cancer. J Chromatogr A. 2020; 1629: 461503.

[109] Kim M , Vogtmann E , Ahlquist DA , et al. Fecal metabolomic signatures in colorectal adenoma patients are associated with gut microbiota and early events of colorectal cancer pathogenesis. mBio. 2020; 11 (1): e03186- 19.

[110] Yang Y , Misra BB , Liang L , et al. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer. Theranostics. 2019; 9 (14): 4101- 4114.

[111] Coker OO , Liu C , Wu WKK , et al. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers. Microbiome. 2022; 10 (1): 35.

[112] Russo F , Linsalata M , Orlando A . Probiotics against neoplastic transformation of gastric mucosa: effects on cell proliferation and polyamine metabolism. World J Gastroenterol. 2014; 20 (37): 13258- 13272.

[113] Dai D , Yang Y , Yu J , et al. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 2021; 12 (12): 1104.

[114] Guo H , Chou WC , Lai Y , et al. Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites. Science. 2020; 370 (6516): eaay9097.

[115] Lloyd-Price J , Arze C , Ananthakrishnan AN , et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019; 569 (7758): 655- 662.

[116] Tan AH , Chong CW , Lim SY , et al. Gut microbial ecosystem in Parkinson disease: new clinicobiological insights from multi-omics. Ann Neurol. 2021; 89 (3): 546- 559.

[117] Zhou W , Sailani MR , Contrepois K , et al. Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature. 2019; 569 (7758): 663- 671.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Malignancy Spectrum published by John Wiley & Sons Australia, Ltd on behalf of Higher Education Press.